← Back to Search

Breast Cancer Education Program for Breast Cancer (AIBCS Trial)

N/A
Waitlist Available
Led By Jamilia R Sly, PhD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate
Awards & highlights

AIBCS Trial Summary

This trial will test an adapted intervention to increase breast cancer screening rates for African-born immigrants living in New York City. The intervention is based on the Health Belief Model, which posits that making a decision to engage in a health behavior is determined by weighing perceived threats versus benefits.

Eligible Conditions
  • Breast Cancer

AIBCS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mammogram intention
Mammogram location and appointment
Secondary outcome measures
Comparison Perceived Risk
Perceived Risk
Self-Efficacy for Mammography

AIBCS Trial Design

1Treatment groups
Experimental Treatment
Group I: Breast Cancer Education ProgramExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
African Immigrant Breast Cancer Education Program
2020
N/A
~160

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
858 Previous Clinical Trials
524,131 Total Patients Enrolled
11 Trials studying Breast Cancer
24,062 Patients Enrolled for Breast Cancer
National Institute on Minority Health and Health Disparities (NIMHD)NIH
380 Previous Clinical Trials
1,215,499 Total Patients Enrolled
4 Trials studying Breast Cancer
1,855 Patients Enrolled for Breast Cancer
Jamilia R Sly, PhDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been recruited to participate in this clinical trial?

"Affirmative. According to data on clinicaltrials.gov, this medical study is still enrolling patients after first being posted in February 2020 and most recently updated in August 2022. The project requires 168 volunteers from a single centre to complete the trial."

Answered by AI

Does this research program provide the opportunity for individuals over 35 to participate?

"The eligibility requirements for this study necessitate that participants are older than 18 and younger than 74."

Answered by AI

Could I feasibly participate in this research endeavor?

"This research is enrolling 168 participants with breast cancer between the age of majority and 74. To qualify, applicants must be over 18 years old."

Answered by AI

Is this experimental protocol still recruiting participants?

"Affirmative. The information on clinicaltrials.gov indicates that recruitment for this medical experiment is still open, which was initially posted on February 5th of 2020 and recently revised on August 22nd 2022. This trial requires 168 participants to be recruited from 1 location."

Answered by AI
Recent research and studies
~30 spots leftby Apr 2025